54 related articles for article (PubMed ID: 34022224)
1. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
Nagashima S; Maruyama J; Honda K; Kondoh Y; Osada H; Nawa M; Nakahama KI; Ishigami-Yuasa M; Kagechika H; Sugimura H; Iwasa H; Arimoto-Matsuzaki K; Nishina H; Hata Y
J Biol Chem; 2021 Jul; 297(1):100803. PubMed ID: 34022224
[TBL] [Abstract][Full Text] [Related]
2. HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation.
Yang R; Wu Y; Wang M; Sun Z; Zou J; Zhang Y; Cui H
Oncotarget; 2015 Apr; 6(10):7644-56. PubMed ID: 25760078
[TBL] [Abstract][Full Text] [Related]
3. A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer.
Yang WH; Huang Z; Wu J; Ding CC; Murphy SK; Chi JT
Mol Cancer Res; 2020 Jan; 18(1):79-90. PubMed ID: 31641008
[TBL] [Abstract][Full Text] [Related]
4. Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription.
Kaukonen R; Mai A; Georgiadou M; Saari M; De Franceschi N; Betz T; Sihto H; Ventelä S; Elo L; Jokitalo E; Westermarck J; Kellokumpu-Lehtinen PL; Joensuu H; Grenman R; Ivaska J
Nat Commun; 2016 Aug; 7():12237. PubMed ID: 27488962
[TBL] [Abstract][Full Text] [Related]
5. CSE1L as a prognostic biomarker associated with pan cancer immune infiltration and drug sensitivity.
Li H; Wang L; Ruan Z; Li X; Yang Y; Fang J; Wang R
Expert Rev Clin Immunol; 2024 May; ():. PubMed ID: 38752776
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule inhibition of Lats kinases may promote Yap-dependent proliferation in postmitotic mammalian tissues.
Kastan N; Gnedeva K; Alisch T; Petelski AA; Huggins DJ; Chiaravalli J; Aharanov A; Shakked A; Tzahor E; Nagiel A; Segil N; Hudspeth AJ
Nat Commun; 2021 May; 12(1):3100. PubMed ID: 34035288
[TBL] [Abstract][Full Text] [Related]
7. Cell type-specific YAP1-WWTR1/TAZ transcriptional responses after autophagy perturbations are determined by levels of α-catenins (CTNNA1 and CTNNA3).
Pavel M; Park SJ; Tanasa R; Rubinsztein DC
Autophagy; 2021 Jul; 17(7):1788-1790. PubMed ID: 34036899
[TBL] [Abstract][Full Text] [Related]
8. Upregulated PPARG2 facilitates interaction with demethylated AKAP12 gene promoter and suppresses proliferation in prostate cancer.
Li F; Lu T; Liu D; Zhang C; Zhang Y; Dong F
Cell Death Dis; 2021 May; 12(6):528. PubMed ID: 34023860
[TBL] [Abstract][Full Text] [Related]
9. Enrichment of NPC1-deficient cells with the lipid LBPA stimulates autophagy, improves lysosomal function, and reduces cholesterol storage.
Ilnytska O; Lai K; Gorshkov K; Schultz ML; Tran BN; Jeziorek M; Kunkel TJ; Azaria RD; McLoughlin HS; Waghalter M; Xu Y; Schlame M; Altan-Bonnet N; Zheng W; Lieberman AP; Dobrowolski R; Storch J
J Biol Chem; 2021 Jul; 297(1):100813. PubMed ID: 34023384
[TBL] [Abstract][Full Text] [Related]
10. Disrupting interferon-alpha and NF-kappaB crosstalk suppresses IFITM1 expression attenuating triple-negative breast cancer progression.
Provance OK; Geanes ES; Lui AJ; Roy A; Holloran SM; Gunewardena S; Hagan CR; Weir S; Lewis-Wambi J
Cancer Lett; 2021 Aug; 514():12-29. PubMed ID: 34022283
[TBL] [Abstract][Full Text] [Related]
11. NOX4 regulates macrophage apoptosis resistance to induce fibrotic progression.
Larson-Casey JL; Gu L; Kang J; Dhyani A; Carter AB
J Biol Chem; 2021 Jul; 297(1):100810. PubMed ID: 34023385
[TBL] [Abstract][Full Text] [Related]
12. Cornelia de Lange syndrome-associated mutations cause a DNA damage signalling and repair defect.
Olley G; Pradeepa MM; Grimes GR; Piquet S; Polo SE; FitzPatrick DR; Bickmore WA; Boumendil C
Nat Commun; 2021 May; 12(1):3127. PubMed ID: 34035299
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling.
Cui X; Wang H; Wu X; Huo K; Jing X
J Ovarian Res; 2021 May; 14(1):71. PubMed ID: 34034774
[TBL] [Abstract][Full Text] [Related]
14. In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy.
Dai M; Yan G; Wang N; Daliah G; Edick AM; Poulet S; Boudreault J; Ali S; Burgos SA; Lebrun JJ
Nat Commun; 2021 May; 12(1):3055. PubMed ID: 34031411
[TBL] [Abstract][Full Text] [Related]
15. Nucleocytoplasmic Shuttling of the Mechanosensitive Transcription Factors MRTF and YAP /TAZ.
Kofler M; Kapus A
Methods Mol Biol; 2021; 2299():197-216. PubMed ID: 34028745
[TBL] [Abstract][Full Text] [Related]
16. Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors.
Sule A; Van Doorn J; Sundaram RK; Ganesa S; Vasquez JC; Bindra RS
NAR Cancer; 2021 Jun; 3(2):zcab018. PubMed ID: 34027408
[TBL] [Abstract][Full Text] [Related]
17. NADPH Oxidase 5 and Melatonin: Involvement in Ram Sperm Capacitation.
Miguel-Jiménez S; Pina-Beltrán B; Gimeno-Martos S; Carvajal-Serna M; Casao A; Pérez-Pe R
Front Cell Dev Biol; 2021; 9():655794. PubMed ID: 34026754
[TBL] [Abstract][Full Text] [Related]
18. PRMT5 Enables Robust STAT3 Activation via Arginine Symmetric Dimethylation of SMAD7.
Cai C; Gu S; Yu Y; Zhu Y; Zhang H; Yuan B; Shen L; Yang B; Feng XH
Adv Sci (Weinh); 2021 May; 8(10):2003047. PubMed ID: 34026434
[TBL] [Abstract][Full Text] [Related]
19. Proteasome Inhibition Suppresses KIT-Independent Gastrointestinal Stromal Tumors Via Targeting Hippo/YAP/Cyclin D1 Signaling.
Chen T; Ni N; Yuan L; Xu L; Bahri N; Sun B; Wu Y; Ou WB
Front Pharmacol; 2021; 12():686874. PubMed ID: 34025442
[No Abstract] [Full Text] [Related]
20. Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway Inhibition.
Maugeri G; Bucolo C; Drago F; Rossi S; Di Rosa M; Imbesi R; D'Agata V; Giunta S
Front Pharmacol; 2021; 12():684680. PubMed ID: 34025440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
